PROTECT MULTI AKTIENANLEIHE - BASF/BAYER/MERCK Stock

Certificat

DE000VM2MFV4

Market Closed - Deutsche Boerse AG 14:02:17 2024-05-15 EDT
69.9 EUR +0.36% Intraday chart for PROTECT MULTI AKTIENANLEIHE - BASF/BAYER/MERCK
Current month+6.88%
1 month+10.27%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-15 69.9 +0.36%
24-05-14 69.65 -0.43%
24-05-13 69.95 +1.57%
24-05-10 68.87 +0.95%
24-05-09 68.22 -0.20%

Delayed Quote Deutsche Boerse AG

Last update May 15, 2024 at 02:02 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying MERCK KGAA
IssuerLogo Issuer Vontobel Vontobel
WKN VM2MFV
ISINDE000VM2MFV4
Date issued 2023-10-09
Strike 155
Maturity 2024-09-20 (128 Days)
Parity 0.16 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 100.9
Lowest since issue 62.3

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
165.8 EUR
Average target price
180.1 EUR
Spread / Average Target
+8.61%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW